Health Care Reform

Regeneron will provide Otarmeni — a new gene therapy for an ultra-rare form of genetic hearing loss recently approved by the U.S. Food and Drug Administration — for free under a new agreement with the U.S. government.

Asking the right questions can help benefits professionals and employers find a PBM who is truly working as a partner to cut prescription drug costs.

Connecticut Insurance Department cited five major insurers — Aetna, Anthem, ConnectiCare, Cigna, and UnitedHealthcare — for failing to provide mental health and substance use coverage equal to their medical and surgical benefits.

An employer group wants DOL officials to treat access to the data as part of a plan service provider's pay.

A new House bill would apply the penalty to insurers that reject more than 25% of claims.

CenterWell Pharmacy (a part of Humana Inc.) announced plans to develop end-to-end employer prescription solutions with Cost Plus Drugs.